Roberta Gualtierotti

5.3k total citations · 1 hit paper
106 papers, 2.5k citations indexed

About

Roberta Gualtierotti is a scholar working on Hematology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Roberta Gualtierotti has authored 106 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 26 papers in Rheumatology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Roberta Gualtierotti's work include Hemophilia Treatment and Research (21 papers), Systemic Sclerosis and Related Diseases (20 papers) and Systemic Lupus Erythematosus Research (15 papers). Roberta Gualtierotti is often cited by papers focused on Hemophilia Treatment and Research (21 papers), Systemic Sclerosis and Related Diseases (20 papers) and Systemic Lupus Erythematosus Research (15 papers). Roberta Gualtierotti collaborates with scholars based in Italy, United States and Netherlands. Roberta Gualtierotti's co-authors include Francesca Ingegnoli, Pier Luigi Meroni, Flora Peyvandi, Roberto Castelli, Massimo Cugno, Patrizia Boracchi, Luigi Piero Solimeno, C. Lubatti, Martina Biggioggero and S. Zeni and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Roberta Gualtierotti

96 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hemophilic arthropathy: Current knowledge and future perspectives

2021 150 citations Roberta Gualtierotti, Luigi Piero Solimeno et al. Journal of Thrombosis and Haemostasis profile →

Peers

Countries citing papers authored by Roberta Gualtierotti

Since Specialization

Citations

This map shows the geographic impact of Roberta Gualtierotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Gualtierotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Gualtierotti more than expected).

Fields of papers citing papers by Roberta Gualtierotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Gualtierotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Gualtierotti. The network helps show where Roberta Gualtierotti may publish in the future.

Co-authorship network of co-authors of Roberta Gualtierotti

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Gualtierotti. A scholar is included among the top collaborators of Roberta Gualtierotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Gualtierotti. Roberta Gualtierotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Challenging Case of Immune-Related Organizing Pneumonitis Following Programmed Cell Death 1 Inhibitor Therapy in Non-Small Cell Lung Cancer 2025 ·Journal of Clinical Medicine Research ·(unknown), Roberta Gualtierotti, (unknown), Barbara Ferrari, (unknown), Flora Peyvandi	0
2	International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology 2024 ·Journal of Thrombosis and Haemostasis ·Suely Meireles Rezende, Ignacio Neumann, Pantep Angchaisuksiri, (unknown), Ana Boban, Adam Cuker, Julie Curtin, Karin Fijnvandraat, Samantha C. Gouw, Roberta Gualtierotti, Michael Makris, (unknown), Niamh O’Connell, Renu Saxena, Midori Shima, Runhui Wu, Frits R. Rosendaal	13
3	Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis 2024 ·Blood Advances ·(unknown), Roberta Gualtierotti, Erica Scalambrino, Marigrazia Clerici, (unknown), (unknown), (unknown), Cristina Novembrino, Carla Valsecchi, Roberta Palla, Flora Peyvandi	6
4	Exploring the Impact of Sex and Gender in Brain Function: Implications and Considerations 2024 ·Advances in Therapy ·Roberta Gualtierotti, C. Bressi, Barbara Garavaglia, Paolo Brambilla	5
5	Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients 2023 ·Journal of Clinical Medicine ·Roberta Gualtierotti, Sharon Fox, (unknown), (unknown), Luca Valenti, María Orietta Borghi, Pier Luigi Meroni, Massimo Cugno, Flora Peyvandi, (unknown)	3
6	Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A 2023 ·Blood Advances ·Pasquale Agosti, Simona Maria Siboni, (unknown), Adriana Torri, Roberta Gualtierotti, Flora Peyvandi	9
7	Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy 2023 ·Blood Advances ·Vincenzo La Mura, (unknown), (unknown), (unknown), Simona Maria Siboni, (unknown), Alessandro Ciavarella, Roberta Gualtierotti, Anna Ludovica Fracanzani, Angelo Sangiovanni, Flora Peyvandi	11
8	Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia 2023 ·Journal of Clinical Medicine ·(unknown), Samantha Pasca, (unknown), Roberta Gualtierotti, Pier Mannuccio Mannucci	2
9	Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit 2022 ·Journal of Clinical Medicine ·Roberta Gualtierotti, (unknown), Paolo Rossi, Matteo Rota, Paolo Bucciarelli, Barbara Ferrari, (unknown), Chiara Suffritti, Massimo Cugno, Flora Peyvandi, (unknown)	3
10	Updates on Novel Non-Replacement Drugs for Hemophilia 2022 ·Pharmaceuticals ·Roberta Gualtierotti, Samantha Pasca, Alessandro Ciavarella, (unknown), (unknown), Isabella Garagiola, Chiara Suffritti, Simona Maria Siboni, Flora Peyvandi	20
11	The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy 2022 ·PLoS ONE ·(unknown), Barbara Ferrari, Paolo Rossi, Vincenzo La Mura, Andrea Artoni, Roberta Gualtierotti, Ida Martinelli, (unknown), Alessandra Bandera, Andrea Gori, Francesco Blasi, Valter Monzani, Giorgio Costantino, Sergio Harari, Frits R. Rosendaal, Flora Peyvandi, (unknown)	0
12	Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report 2022 ·Rheumatology and Therapy ·Roberta Gualtierotti, (unknown), Eugenia Biguzzi, (unknown), Alessandra Iurlo, Luigi Piero Solimeno, Flora Peyvandi	1
13	Ultrasound Features of Adhesive Capsulitis 2021 ·Rheumatology and Therapy ·(unknown), Roberta Gualtierotti, (unknown), (unknown), Luca Maria Sconfienza, (unknown), Patrizia Pacini, Mario Miccoli, Stefano Galletti	24
14	Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study 2020 ·Journal of Clinical Medicine ·(unknown), Roberta Gualtierotti, Pasquale Agosti, Maria Pia Adorni, Francesca Ingegnoli, Matteo Rota, Franco Bernini, Pier Luigi Meroni, Nicoletta Ronda	23
15	Vitamin D and Anti-Phospholipid Antibody Syndrome 2018 ·The Open Rheumatology Journal ·Roberta Gualtierotti, (unknown), Elena Raschi, María Orietta Borghi, Pier Luigi Meroni	0
16	Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade. 2016 ·PubMed ·Roberta Gualtierotti, Francesca Ingegnoli, Samantha Griffini, Elena Grovetti, Pier Luigi Meroni, Massimo Cugno	26
17	The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling 2016 ·Stem Cells and Development ·Giovanni Marfia, Stefania Elena Navone, Loubna Abdel Hadi, Moira Paroni, Valeria Berno, Matteo Beretta, Roberta Gualtierotti, Francesca Ingegnoli, Vincenzo Levi, Monica Miozzo, Jens Geginat, Lorenzo Fassina, Paolo Rampini, Carlo Tremolada, Laura Riboni, Rolando Campanella	30
18	Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds 2015 ·Organogenesis ·Giovanni Marfia, Stefania Elena Navone, Clara Di Vito, Nicola Ughi, Silvia Tabano, Monica Miozzo, Carlo Tremolada, (unknown), Chiara Crotti, Francesca Ingegnoli, Paolo Rampini, Laura Riboni, Roberta Gualtierotti, Rolando Campanella	91
19	Gene Expression Profile Analysis of Human Mesenchymal Stem Cells from Herniated and Degenerated Intervertebral Discs Reveals Different Expression of Osteopontin 2014 ·Stem Cells and Development ·Giovanni Marfia, Stefania Elena Navone, Clara Di Vito, Silvia Tabano, Lorenzo Giammattei, Andrea Di Cristofori, Roberta Gualtierotti, Carlo Tremolada, M Zavanone, Manuela Caroli, (unknown), Monica Miozzo, Paolo Rampini, Laura Riboni, Rolando Campanella	16
20	PRINCE: prognostic index for nailfold capillaroscopic examination for identifying raynaud's phenomenon at high risk of developing into a scleroderma spectrum disorder 2008 ·Annals of the Rheumatic Diseases ·Francesca Ingegnoli, Roberta Gualtierotti, Patrizia Boracchi, C. Lubatti, (unknown), S. Zeni, F Fantini	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact